Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George L Scheffer

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Cytometry|July 13, 2002
Flow cytometric analysis of breast cancer resistance protein expression and functionHans Minderman, Attaya Suvannasankha, Kieran L O'Loughlin, et al.
Molecular Pharmaceutics|January 15, 2008
Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesityQiuqiong Cheng, Lauren M Aleksunes, José E Manautou, et al.
Plos One|November 21, 2012
Expression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variationsIldikó Kasza, György Várady, Hajnalka Andrikovics, et al.
Molecular Cancer Therapeutics|February 26, 2009
Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different originsClara Lemos, Ietje Kathmann, Elisa Giovannetti, et al.
Immunology and Cell Biology|March 30, 2011
Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP)Rieneke van de Ven, Jelle J Lindenberg, Anneke W Reurs, et al.
Biochemical and Biophysical Research Communications|February 22, 2002
Structural domains of vault proteins: a role for the coiled coil domain in vault assemblyArend van Zon, Marieke H Mossink, Martijn Schoester, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2010
Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell linesWouter F W Bierman, George L Scheffer, Antoinet Schoonderwoerd, et al.
Current Drug Targets|December 6, 2014
The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinibLetizia Porcelli, Elisa Giovannetti, Yehuda G Assaraf, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|July 18, 2002
Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancerMariël Brinkhuis, Miguel A Izquierdo, Jan P A Baak, et al.
Journal for Immunotherapy of Cancer|October 29, 2025
PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironmentLisa A King, Myrthe Veth, Marieke Roos, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Cytometry|July 13, 2002
Flow cytometric analysis of breast cancer resistance protein expression and functionHans Minderman, Attaya Suvannasankha, Kieran L O'Loughlin, et al.
Molecular Pharmaceutics|January 15, 2008
Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesityQiuqiong Cheng, Lauren M Aleksunes, José E Manautou, et al.
Plos One|November 21, 2012
Expression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variationsIldikó Kasza, György Várady, Hajnalka Andrikovics, et al.
Molecular Cancer Therapeutics|February 26, 2009
Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different originsClara Lemos, Ietje Kathmann, Elisa Giovannetti, et al.
Immunology and Cell Biology|March 30, 2011
Preferential Langerhans cell differentiation from CD34(+) precursors upon introduction of ABCG2 (BCRP)Rieneke van de Ven, Jelle J Lindenberg, Anneke W Reurs, et al.
Biochemical and Biophysical Research Communications|February 22, 2002
Structural domains of vault proteins: a role for the coiled coil domain in vault assemblyArend van Zon, Marieke H Mossink, Martijn Schoester, et al.
The Journal of Antimicrobial Chemotherapy|June 17, 2010
Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell linesWouter F W Bierman, George L Scheffer, Antoinet Schoonderwoerd, et al.
Current Drug Targets|December 6, 2014
The EGFR pathway regulates BCRP expression in NSCLC cells: role of erlotinibLetizia Porcelli, Elisa Giovannetti, Yehuda G Assaraf, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|July 18, 2002
Expression of multidrug resistance-associated markers, their relation to quantitative pathologic tumour characteristics and prognosis in advanced ovarian cancerMariël Brinkhuis, Miguel A Izquierdo, Jan P A Baak, et al.
Journal for Immunotherapy of Cancer|October 29, 2025
PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironmentLisa A King, Myrthe Veth, Marieke Roos, et al.
Pageof 9